companydata.dkcompanydata.dk

2N Pharma ApS: Financial statements 2023

CVR: 41169303

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

2N Pharma ApS (CVR 41169303) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 543,215 and a net result of DKK -346,799 compared with DKK 270,099 the year before. That is a decrease of 75.6% compared with the year before. Equity in the 2023 report amounted to DKK 10,701,248. The solvency ratio was 49.1%. The company had 3 employees in the financial year.

Gross Profit
DKK 543,215
Profit/Loss
DKK -346,799
Equity
DKK 10,701,248
Total Assets
DKK 21,812,852
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-543 t.-347 t.10.7 mio.3
2022-2.2 mio.270 t.11 mio.3
2021-1.5 mio.-318 t.8.9 mio.5
2020-336 t.-188 t.-148 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

John Kemp leaves the board of 2N Pharma ApSSep 4, 2023

As of September 4, 2023, John Kemp has left the board of directors of 2N Pharma ApS.

Alex Leech leaves the board of 2N Pharma ApSAug 31, 2023

As of August 31, 2023, Alex Leech has left the board of directors of 2N Pharma ApS.

2N Pharma ApS: The 2022 annual report is outJul 3, 2023

2N Pharma ApS has published its annual report for 2022. Gross profit came to DKK 2,221,899, and the net result was DKK 270,099.

About 2N Pharma ApS

2N Pharma ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2020. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by 2N Pharma Holding ApS. According to the 2024 annual report, the company had an average of 3 employees. In 2024, the company reported a gross profit of DKK 1,077,483 and a net result of DKK -396,379 compared with DKK -346,799 the year before. Equity in the 2024 report amounted to DKK 10,304,869.

Source: annual report 2024, Danish Business Authority

Other financial years